WALTHAM, Mass.–(BUSINESS WIRE)–Augmenix, Inc. a medical technology company that develops, manufactures,
and sells proprietary absorbable hydrogels that separate and protect
organs at risk during prostate radiotherapy, today announced that it
will present at the Piper Jaffray 28th Annual Healthcare
Conference at the Lotte New York Palace Hotel in New York City on
Wednesday, November 30, 2016. John Pedersen, Chief Executive Officer is
scheduled to present at 1:10 p.m. Eastern Time.
About Augmenix, Inc.
Augmenix, Inc. is a privately held company based in the Boston area
focused on the development and commercialization of radiation oncology
products using its proprietary hydrogel technology. The company was
founded by Incept LLC in 2008 and is funded by several leading venture
capital groups. More information about Augmenix can be found at http://www.Augmenix.com.
Eileen Gardner, RN, 781-902-1625